ONFI (clobazam) Tablets now Available in the U.S. at Pharmacies
DEERFIELD, Ill.–(BUSINESS WIRE)–Lundbeck announced today that ONFI Tablets are now available for prescribing in the United States. The FDA recently approved ONFI for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients two years and older.1 ONFI is an oral anti-epileptic drug (AED) of the benzodiazepine class, and is a 1,5 benzodiazepine.1 ONFI [...]Learn more
Help us Better Educate First Responders in 2012
Josh, an Epilepsy Foundation Eastern PA volunteer, first started working with the EFEPA as a Camp Achieve counselor which led him to establish the EFEPA Youth Council. He is taking his passion for the Foundation and his career as a First Responder to help the EFEPA with a new, important initiative: educating emergency personnel on [...]Learn more
Eastern PA Region Celebrates November Epilepsy Awareness Month
The EFEPA joined in the national celebration of Epilepsy Awareness Month this November by holding several events and awareness activities throughout our 18-county service area. In Philadelphia, well-known buildings and landmarks like the National Constitution Center, Ben Franklin Bridge, Liberty Place and the PECO Building were lit up purple, the international color of epilepsy. On a daily [...]Learn more
Call to Action!
FUNDING FOR EPILEPSY SERVICES CUT ACT NOW – EPILEPSY HAS BEEN OVERLOOKED & UNDER FUNDED FOR TOO LONG! The Pennsylvania Senate plans to vote on a state budget proposal within the next few days, BUT the current budget proposals do not have a line item or funding for epilepsy services! PLEASE, take the time today [...]Learn more